Abstract
During the COVID-19 epidemic, the treatment of critically ill patients has been increasingly difficult and challenging. During the epidemic, some patients with neurological diseases also have COVID-19, which could be misdiagnosed and cause silent transmission and nosocomial infection. Such risk is high in a neurological intensive care unit (NCU). Therefore, prevention and control of epidemic in critically ill patients is of utmost importance. The principle of NCU care should include comprehensive screening and risk assessment, weighing risk against benefits and reducing the risk of COVID-19 transmission while treating patients as promptly as possible.
Keywords:
infection.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Publication types
-
Practice Guideline
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Betacoronavirus / pathogenicity*
-
COVID-19
-
Consensus
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / prevention & control*
-
Coronavirus Infections / transmission
-
Coronavirus Infections / virology
-
Critical Illness
-
Cross Infection / diagnosis
-
Cross Infection / prevention & control*
-
Cross Infection / transmission
-
Cross Infection / virology
-
Host-Pathogen Interactions
-
Humans
-
Infection Control / standards*
-
Infectious Disease Transmission, Patient-to-Professional / prevention & control*
-
Intensive Care Units / standards*
-
Nervous System Diseases / diagnosis
-
Nervous System Diseases / therapy*
-
Neurology / standards*
-
Occupational Health
-
Pandemics / prevention & control*
-
Patient Safety
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / prevention & control*
-
Pneumonia, Viral / transmission
-
Pneumonia, Viral / virology
-
Risk Assessment
-
Risk Factors
-
SARS-CoV-2
-
Treatment Outcome